Follow-The-Filings

Security · featured owners

RCEL Avita Medical Inc.

Health Care COM Equity among managers we track

RCEL (Avita Medical Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 17 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 1.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K/A 5.07 Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 5.02,5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 1.01,1.02,2.02,2.03,3.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 1.01,2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 16 rows shown

Filed Form Detail Links
4/A Period Jun 12, 2026 Filing Doc
4 Period Jun 12, 2026 Filing Doc
4 Period Jun 9, 2026 Filing Doc
4 Period Jun 9, 2026 Filing Doc
4 Period Jun 3, 2026 Filing Doc
4 Period Jun 3, 2026 · 6 forms Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period May 29, 2026 · 2 forms Filing Doc
4 Period May 20, 2026 Filing Doc
4 Period May 19, 2026 Filing Doc
4 Period Mar 11, 2026 Filing Doc
4 Period Feb 19, 2026 Filing Doc
4 Period Feb 18, 2026 · 2 forms Filing Doc
4 Period Aug 28, 2025 Filing Doc
4 Period Aug 26, 2025 Filing Doc
4 Period Aug 19, 2025 Filing Doc

Updated 5 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $63.89M $70.88M
Gross profit $42.36M $55.16M $58.82M
Gross margin * — 86.3% 83.0%
Net income -$35.38M -$61.84M -$48.59M
Net margin * — -96.8% -68.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $104.01M $57M $35.49M
Total non-current assets * $7.63M $22.71M $20.9M
Total assets $111.64M $79.71M $56.39M
Total current liabilities $13.2M $20.16M $62.68M
Total non-current liabilities * $48.69M $54.81M $10.36M
Total equity $49.06M $4.5M -$16.65M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$38.01M -$48.94M -$31.2M
Cash from investing $1.61M $37.36M $12.45M
Cash from financing $40.37M $3.51M $14.94M
Net change in cash $3.95M -$8.07M -$3.81M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders